We are live on ! Find out more
TBPH icon

Theravance Biopharma
TBPH

107 hedge funds and large institutions have $946M invested in Theravance Biopharma in 2020 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 33 increasing their positions, 32 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

6,800% more call options, than puts

Call options by funds: $69K | Put options by funds: $1K

22% more capital invested

Capital invested by funds: $775M → $946M (+$170M)

3% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 32

0.62% more ownership

Funds ownership: 82.6% → 83.21% (+0.62%)

9% less funds holding

Funds holding: 118 → 107 (-11)

42% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 26

Holders
107
Holders Change
-11
Holders Change %
-9.32%
% of All Funds
1.89%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
15
Increased
33
Reduced
32
Closed
26
Calls
$69K
Puts
$1K
Net Calls
+$68K
Net Calls Change
+$230K

Top Buyers

Rank Fund Capital Flow
1
GPP
Great Point Partners
Connecticut
+$14.8M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$13.3M
3
LCM
Laurion Capital Management
New York
+$11.2M
4
Morgan Stanley
Morgan Stanley
New York
+$8.39M
5
BlackRock
BlackRock
New York
+$3.08M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$10.3M
2
RCMNY
Rubric Capital Management (New York)
New York
-$8.14M
3
Norges Bank
Norges Bank
Norway
-$6.32M
4
RSCM
Rock Springs Capital Management
Maryland
-$2.62M
5
Citadel Advisors
Citadel Advisors
Florida
-$2.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$3.82M -$840K -46,771 -18%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$3.66M -$87.9K -4,895 -2%
N
28
Nuveen
North Carolina
$3.38M -$350K -19,473 -9%
PAM
29
Panagora Asset Management
Massachusetts
$3.29M +$1.62M +90,026 +95%
UBS Group
30
UBS Group
Switzerland
$2.99M +$1.53M +85,425 +103%
Russell Investments Group
31
Russell Investments Group
United Kingdom
$1.83M -$178K -9,937 -9%
California Public Employees Retirement System
32
California Public Employees Retirement System
California
$1.82M -$35.9K -2,000 -2%
Swiss National Bank
33
Swiss National Bank
Switzerland
$1.78M – – –
MOACM
34
Mutual of America Capital Management
New York
$1.55M -$33.1K -1,844 -2%
Bank of America
35
Bank of America
North Carolina
$1.45M +$217K +12,070 +17%
AllianceBernstein
36
AllianceBernstein
Tennessee
$1.36M – – –
California State Teachers Retirement System (CalSTRS)
37
California State Teachers Retirement System (CalSTRS)
California
$1.25M +$18.1K +1,006 +1%
Macquarie Group
38
Macquarie Group
Australia
$1.25M +$335K +18,675 +36%
DekaBank Deutsche Girozentrale
39
DekaBank Deutsche Girozentrale
Germany
$1.17M +$569K +31,700 +92%
State of Wisconsin Investment Board
40
State of Wisconsin Investment Board
Wisconsin
$1.17M -$147K -8,200 -11%
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$1.16M +$60.6K +3,375 +5%
PAMU
42
Pictet Asset Management (UK)
United Kingdom
$1.14M – – –
CS
43
Credit Suisse
Switzerland
$1.11M +$315K +17,534 +39%
UBS AM
44
UBS AM
Illinois
$1.08M +$312K +17,366 +40%
RA
45
Royce & Associates
New York
$1.05M -$616K -34,291 -37%
PP
46
PDT Partners
New York
$969K -$207K -11,539 -17%
TLP
47
Tri Locum Partners
New York
$877K +$886K +49,373 New
SG Americas Securities
48
SG Americas Securities
New York
$750K +$758K +42,230 New
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$736K – – –
TRSOTSOK
50
Teachers Retirement System of the State of Kentucky
Kentucky
$723K – – –
1
2
3 4 5

TBPH Hedge Fund Activity: Q4 2020 in Review

107 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Theravance Biopharma (TBPH) for Q4 2020, worth a combined $946M — up 22% from $775M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of TBPH and 15 opened new positions — a net loss of 11 holders — while 32 trimmed existing stakes and 33 added.

The largest buyer was Great Point Partners, opening a new position worth an estimated $14.8M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $10.3M sold.

  • 107 institutional investors held Theravance Biopharma (TBPH) as of Q4 2020, down from 118 in Q3 2020.
  • Funds reported $946M of Theravance Biopharma stock for Q4 2020, up 22% quarter-over-quarter.
  • 15 funds opened new Theravance Biopharma positions in Q4 2020 and 26 closed out, a net change of -11 holders.
  • The largest Theravance Biopharma buyer in Q4 2020 was Great Point Partners, an estimated $14.8M added.
  • The largest Theravance Biopharma seller in Q4 2020 was Adage Capital Partners, an estimated $10.3M sold.

Based on aggregated 13F filings for Q4 2020.